Celsius
Celsius' revenue rose 85.5% to $2.5 billion in fiscal 2025. Its operating margin was 5.6%, down from 11.5% a year earlier. Free cash flow was $323 million, up 35.0%. It paid out $6 million in dividends and buybacks, 2% of free cash flow. The diluted share count rose 7.4%.
Operating margin is operating income as a share of revenue. Free cash flow is cash from operations minus capital spending. Return on capital is after-tax operating income as a share of the money invested in the business: debt plus equity, minus cash. Market cap is the last closing share price times the latest diluted share count, so it is approximate. P/E is the last close divided by diluted earnings per share over the last four quarters, or the latest fiscal year where the quarters aren't available; there is none when the company made a loss.
What Celsius does
Celsius makes and sells energy drinks and wellness beverages in the United States and abroad. Its portfolio is mainly energy drinks under the Celsius, Alani Nu and Rockstar brands, with Celsius and Alani Nu also offering other wellness products. Many of its drinks contain caffeine and ingredients such as green tea extract, vitamins and electrolytes, and many have zero sugar. The products are sold in the U.S., Canada, Europe, the Middle East and Asia-Pacific.
It sells through grocery, natural-food and convenience stores, fitness centers, mass-market and vitamin retailers and e-commerce sites. It relies on distributors, and Pepsi is its primary distributor in the U.S. and Canada for Celsius, Alani Nu and Rockstar. Under a long-term arrangement it calls the Captaincy, Pepsi has agreed to use commercially reasonable efforts to sell and distribute Celsius products in the U.S. Pepsi holds preferred stock in Celsius and two seats on its Board. Celsius relies mostly on co-packers, which are outside companies that make its drinks.
Celsius bought the Alani Nu brand for a total that included $1,275.0 million in cash, shares of its common stock, and up to $25.0 million more in cash. It also acquired the Rockstar business in the U.S. and Canada as part of its deals with Pepsi. It funded part of the Alani Nu cash price with a term loan, which it later refinanced with a new, smaller one. Celsius says it faces significant competition from other functional beverage companies.
Its biggest risks, as it describes them
- Relying on distributors, and on Pepsi in particular, so a dispute or an end to those arrangements could hurt it.
- Pepsi's larger ownership stake and Board seats may give it more influence over Celsius' strategy.
- Trouble integrating Alani Nu, Rockstar or other acquired businesses, or not reaching the expected benefits.
- Reliance on co-packers to make its drinks, and the cost or shortage of raw materials.
- Its focus on the functional beverage category, and strong competition within it.
Charts show fiscal years, from the 10-K filings.
Revenue and margins
Net income and earnings per share
From fiscal 2019 to 2025, earnings per share grew 30.8% a year and net income 48.7% a year, as new shares raised the share count by 32% and diluted each share's earnings.
Returns on capital
Cash flow
Payouts and share count
Valuation
Two ways to value Celsius yourself, both starting from its filings: a discounted cash flow model and the price-to-earnings method.
Discounted cash flow (DCF)
A discounted cash flow (DCF) model values a business as the cash it may generate in future, discounted back to today. The starting figures come from Celsius' 10-K (or, for net cash and shares, its latest 10-Q) and the assumptions are yours: start from one of three example scenarios, then change any figure to see what it implies for a share, and how that compares with the last share price.
Value per share on three example scenarios, from Celsius' fiscal 2025 free cash flow of $323M, net cash of −$278M at December 31, 2025 and 255 million diluted shares, from its filings. The scenarios are fitted to Celsius: the base scenario's growth in years 1 to 5 is its revenue growth over the last 3 years, 56.7% a year, kept between 0% and 20%; the cautious and optimistic ones are lower and higher, and growth in years 6 to 10 is halfway to the long-run rate. The base scenario's discount rate is 9%: 7% for a stable business (Soft Drinks & Non-alcoholic Beverages), plus 1 point as a smaller company, worth $7.2B, plus 1 point for unsteady results (a loss in fiscal 2022); the cautious and optimistic ones use a point more and a point less. Select one to load it into the calculator. These are the model's arithmetic on those assumptions, not a forecast or a price target.
- Last close, October 26, 2026
- $28.15
- Value on these assumptions, against the last close
- —
- Cash flows in years 1 to 10, valued today
- —
- Everything after year 10, valued today
- —
- Plus net cash
- —
- Share of value from after year 10
How the value changes with two assumptions
Price-to-earnings (P/E) method
Another common way to value a company is to multiply its earnings per share by a price-to-earnings (P/E) multiple: the number of years of today's earnings an investor pays for a share. A higher multiple usually means investors expect earnings to grow. Choose a multiple, for example from similar companies, to see the value it gives.
Value per share on three example scenarios, from Celsius' earnings per share of $0.23 (over the last four quarters). Each grows earnings for a year at the cash flow scenarios' rates and applies a multiple to next year's earnings: 24×, the middle of Celsius' own P/E today, its peers' median and its sector's median (the Consumer Staples median) for the base scenario, 20% less and more for the cautious and optimistic ones. The price is brought back a year at 10%, 9% and 8%. Select one to load it into the calculator. These are the model's arithmetic on those assumptions, not a forecast or a price target.
- Last close, October 26, 2026
- $28.15
- Value at this multiple, against the last close
- —
- Celsius' P/E at the last close
- 122.4×
| Company | Last close | Earnings per share | P/E today |
|---|---|---|---|
| CelsiusCELH | $28.15 | $0.23 | 122.4× |
| Vita CocoCOCO | $55.80 | $1.99 | 28.0× |
| Monster BeverageMNST | $46.44 | $2.16 | 21.5× |
| National BeverageFIZZ | $35.82 | $1.86 | 19.3× |
Balance sheet
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | 16 | 614 | 756 | 890 | 399 |
| Debt incl. finance leases | — | — | — | 0 | 677 |
| Net debt (negative means net cash) | — | — | — | −890 | 278 |
| Net debt to EBITDA | — | — | — | −5.5x | 1.6x |
| Debt to equity | — | — | — | 0.0x | 0.6x |
| Interest coverage | −584.3x | — | — | — | 2.9x |
| Current ratio | 2.8x | 5.7x | 4.4x | 3.6x | 1.7x |
| Quick ratio | 0.8x | 4.6x | 3.5x | 3.3x | 1.4x |
Insider trades
Over the 12 months between October 27, 2025 and October 26, 2026, 4 insiders bought $3.2 million of Celsius shares on the open market, and 1 insider sold $147,773.
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Sep 15, 2026 | Damon DeSantisDirector | Bought | 16,000 | $27.95 | $447,200 | Form 4 |
| Sep 15, 2026 | Hal KravitzDirector | Bought | 12,000 | $28.00 | $336,000 | Form 4 |
| Sep 14, 2026 | Damon DeSantisDirector | Bought | 20,000 | $27.65 | $553,000 | Form 4 |
| Sep 10, 2026 | John FieldlyChief Executive Officer, Director | Bought | 18,000 | $27.44 | $493,920 | Form 4 |
| May 22, 2026 | Hal KravitzDirector | Bought | 8,400 | $29.73 | $249,732 | Form 4 |
| May 22, 2026 | John FieldlyChief Executive Officer, Director | Bought | 8,475 | $29.36 | $248,826 | Form 4 |
| May 21, 2026 | Eric HansonPresident & COO | Bought | 7,500 | $29.04 | $217,800 | Form 4 |
| Mar 2, 2026 | Joyce RussellDirector | Sold | 2,880 | $51.31 | $147,773 | Form 4 |
| Nov 13, 2025 | Hal KravitzDirector | Bought | 10,000 | $45.24 | $452,400 | Form 4 |
| Nov 12, 2025 | Eric HansonPresident & COO | Bought | 4,558 | $43.93 | $200,233 | Form 4 |
Piotroski F-score
The F-score counts how many of nine simple tests of profitability, funding and efficiency a company passed in a year (Piotroski, 2000). The more tests passed, the stronger the year: 8 or 9 is strong, 0 to 2 weak. Companies that report no gross profit are scored on the other eight.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | Pass | Pass | Pass |
| Cash from operations is positive | Pass | Pass | Pass |
| Return on assets rose | Pass | Fail | Fail |
| Cash from operations exceeds net income | Fail | Pass | Pass |
| Debt fell relative to assets | — | — | Fail |
| Current ratio rose | Fail | Fail | Fail |
| Share count didn't rise | Fail | Fail | Fail |
| Gross margin rose | Pass | Pass | Pass |
| Revenue rose relative to assets | Fail | Fail | Pass |
| F-score | — | — | 5 of 9 |
| Accruals ratio | 6.2% | −7.1% | −7.3% |
Compare
Put Celsius side by side with any other company we cover: revenue, growth, margins, cash flow and returns, with ten years of charts.
Similar companies
| Company | Year | Revenue growth | Operating margin | Free cash flow margin | Return on capital | Net debt to EBITDA | F-score | Compare |
|---|---|---|---|---|---|---|---|---|
| Celsius | FY25 | 85.5% | 5.6% | 12.9% | 25.1% | 1.6x | 5 | |
| National Beverage | FY26 | −1.7% | 19.5% | 13.2% | 65.5% | −1.4x | 7 | Compare |
| Coca-Cola Consolidated | FY25 | 4.8% | 13.2% | 8.6% | 39.7% | 2.2x | — | Compare |
| Monster Beverage | FY25 | 10.7% | 29.2% | 23.7% | 36.1% | −1.1x | 9 | Compare |
| Vita Coco | FY25 | 18.2% | 13.5% | 6.4% | 55.3% | −2.4x | 5 | Compare |
10 years of figures
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | 23 | 36 | 53 | 75 | 131 | 314 | 654 | 1,318 | 1,356 | 2,515 |
| Revenue growth | 32.2% | 58.9% | 45.5% | 42.9% | 74.0% | 140.4% | 108.0% | 101.7% | 2.9% | 85.5% |
| Gross profit | 10 | 15 | 21 | 31 | 61 | 128 | 271 | 633 | 680 | 1,267 |
| Research and development | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 2 | 1 | 2 |
| Operating income | −3 | −8 | −11 | −1 | 8 | −4 | −158 | 266 | 156 | 141 |
| Net income | −3 | −8 | −11 | 10 | 8 | 4 | −187 | 227 | 145 | 108 |
| Diluted EPS (US$) | −0.03 | −0.06 | −0.08 | 0.05 | 0.04 | 0.02 | −0.88 | 0.77 | 0.45 | 0.25 |
| Diluted shares (millions) | 116 | 133 | 150 | 193 | 223 | 233 | 227 | 237 | 237 | 255 |
| Cash flow | ||||||||||
| Cash from operations | −2 | −8 | −12 | 1 | 3 | −97 | 108 | 141 | 263 | 359 |
| Capital expenditure | 0 | 0 | 0 | 0 | 1 | 3 | 8 | 17 | 23 | 36 |
| Free cash flow | −2 | −8 | −12 | 1 | 3 | −100 | 100 | 124 | 240 | 323 |
| Dividends paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share buybacks | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 6 |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 75 | 0 |
| Stock-based compensation | 2 | 2 | 4 | 5 | 6 | 36 | 21 | 21 | 20 | 28 |
| Balance sheet at fiscal year end | ||||||||||
| Cash and short-term investments | 12 | 14 | 8 | 23 | 43 | 16 | 614 | 756 | 890 | 399 |
| Debt incl. finance leases | — | — | 4 | — | — | — | — | — | 0 | 677 |
| Total assets | 18 | 27 | 35 | 90 | 131 | 314 | 1,222 | 1,536 | 1,767 | 5,120 |
| Total liabilities | 7 | 10 | 23 | 27 | 27 | 97 | 358 | 448 | 542 | 2,178 |
| Shareholders' equity | 11 | 17 | 12 | 64 | 104 | 217 | 40 | 264 | 400 | 1,182 |
| Margins and ratios | ||||||||||
| Gross margin | 42.8% | 42.7% | 40.0% | 41.6% | 46.6% | 40.8% | 41.4% | 48.0% | 50.2% | 50.4% |
| Operating margin | −12.5% | −22.3% | −20.2% | −1.9% | 6.0% | −1.3% | −24.1% | 20.2% | 11.5% | 5.6% |
| Net margin | −13.5% | −22.8% | −21.3% | 13.3% | 6.5% | 1.2% | −28.6% | 17.2% | 10.7% | 4.3% |
| Free cash flow margin | −10.5% | −23.4% | −22.4% | 1.3% | 2.2% | −31.7% | 15.3% | 9.4% | 17.7% | 12.9% |
| Return on capital | — | — | — | — | — | — | — | — | — | 25.1% |
| Return on equity | −31.2% | −58.8% | −77.4% | 26.5% | 10.2% | 2.5% | −145.7% | 149.2% | 43.7% | 13.7% |
| Return on assets | −18.6% | −36.8% | −36.3% | 15.9% | 7.7% | 1.8% | −24.4% | 16.4% | 8.8% | 3.1% |
| Net debt to EBITDA | — | — | — | — | — | — | — | — | −5.5x | 1.6x |